Monumedical, LLC
Penryn, CA
- UEI
- KN7MC1A8MKB5
- CAGE
- 6CNM2
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- monumedical.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $109,766 |
| FY2025 | $74,836 |
| FY2024 | $1,324,882 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Air Force | $109,766 |
Contract awards
Similar vendors
About the company
Monumedical, LLC, a small business based in Penryn, California, develops disposable mechanical medication infusion devices for military field care and emergency medicine applications, operating exclusively as a prime contractor under total small business set-asides through the Air Force Research Laboratory.
Monumedical is a limited liability partnership focused on medical device innovation for warfighter and prolonged field care. All four of its federal awards, totaling $1.5 million in combined potential value, are with the Air Force Research Laboratory under the Small Business Innovation Research (SBIR) Program and firm fixed-price purchase orders. The company's product portfolio centers on three infusion device lines: the EZFUSER (a small disposable mechanical medication infuser for warfighters), the MINIFUSER (a compact version), and the MINIFUSER EXTREME (engineered for extreme weather capability). The largest award to date is an $1.25 million purchase order issued August 16, 2024, for EZFUSER Disposable Infuser production, with ultimate completion scheduled July 15, 2026. Earlier awards include a $74.9 million SBIR Phase I contract (December 2023) for EZFUSER development, a $74.8 million SBIR Phase I contract (January 2025) for prolonged field care infusion device development, and a $109.8 million purchase order (June 2026) for the MINIFUSER EXTREME. All performance occurs at the Penryn headquarters.
Customer concentration is singular — the Air Force Research Laboratory funds 100% of awards by both count and dollar value. Activity has remained steady at one award per year across the four years represented in the source, with no subcontract footprint. All work carries the total small business set-aside designation. Obligated dollars match combined potential value across the portfolio, indicating full funding execution.
Quick answers
Is Monumedical, LLC registered in SAM.gov?
Yes. Monumedical, LLC's SAM.gov registration is active through November 13, 2027.
What is Monumedical, LLC's CAGE code?
Monumedical, LLC's CAGE code is 6CNM2, and its Unique Entity ID (UEI) is KN7MC1A8MKB5.
How much has Monumedical, LLC received in federal contracts?
Federal contracts obligated $74,836 to Monumedical, LLC in fiscal year 2025 and $1,509,484 in fiscal years 2023 through 2027.
What is Monumedical, LLC's most recent federal award?
Monumedical, LLC's most recent federal contract award is Minifuser extreme (disposable compact medication infuser with extreme weather capability) (FA864926P0223), from Air Force Research Laboratory (AFMC), on June 25, 2026.
On GovTribe
See Monumedical, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors